Minerva Neurosciences | NERV - Pasivo Circulante

Precio De Mercado
5.51
Cambio Diario
-0.51 -8.47%
Mensual
-24.52%
Anual
280.00%
Q2 Expectativa
5.36




Pasivo Circulante Cambio Fecha
Acadia Pharmaceuticals USD 277.11M 79.47M 2025-12
Adma Biologics USD 69.54M 13.05M 2025-12
ALKERMES USD 543.44M 69.08M 2025-12
Alterity Therapeutics Limited AUD 1.73M 2.77M 2025-12
AstraZeneca USD 30.62B 3.44B 2025-12
BioCryst Pharmaceuticals USD 196.07M 5.83M 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Cipla INR 62.97B 8.13B 2025-09
Clal Biotechnology ILS 6.66M 3.75M 2023-12
Compugen USD 22.57M 2.29M 2025-12
CSL USD 4.61B 207M 2025-12
Eli Lilly USD 35.23B 4.91B 2025-12
Esperion Therapeutics USD 300.81M 58.22M 2025-12
GlaxoSmithKline GBP 21.39B 57M 2025-12
Grifols EUR 2.37B 156.97M 2025-12
Halozyme Therapeutics USD 177.09M 660.14M 2025-12
Ionis Pharmaceuticals USD 783M 120.46M 2025-12
J&J USD 54.13B 3.26B 2025-12
Merck USD 28.63B 2.59B 2025-09
Minerva Neurosciences USD 2.29M 381K 2025-12
Neurocrine Biosciences USD 743.4M 105.4M 2025-12
Novartis USD 27.28B 4.72B 2025-12
Novavax USD 459.95M 30.08M 2025-12
Pfizer USD 36.6B 1.13B 2025-09
Roche Holding CHF 28B 421M 2025-12
Sanofi EUR 28.35B 3.76B 2025-12
Takeda JPY 2.61T 470.53B 2025-12
Vanda Pharmaceuticals USD 145.16M 27.29M 2025-12